Evidence map›Paper›PMID 29194365›Full record

ReviewInternational journal of molecular sciences2017

The Role of Resveratrol in Cancer Therapy.

Jeong-Hyeon Ko, Gautam Sethi, Jae-Young Um, Muthu K Shanmugam, Frank Arfuso, Alan Prem Kumar, Anupam Bishayee, Kwang Seok Ahn

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 400 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
400citing papers in PubMed, 6 pooled it
29.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

400 citing papers in PubMed, 6 syntheses or guidelines pooled it, 767 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Article
  12. The logarithmic phase as a therapeutic direction: evaluating pharmacological strategies against cancer progression.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  13. Review
  14. Article
  15. Review
  16. Reactivation ofInternational journal of molecular sciences · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Article

340 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Jeong-Hyeon KoCollege of Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea. gokjh1647@gmail.com.
Gautam SethiDepartment for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam. gautam.sethi@tdt.edu.vn.
Jae-Young UmCollege of Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea. jyum@khu.ac.kr.
Muthu K ShanmugamDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. phcsmk@nus.edu.sg.
Frank ArfusoStem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth WA 6009, Australia. frank.arfuso@curtin.edu.au.
Alan Prem KumarDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. csiapk@nus.edu.sg.
Anupam BishayeeDepartment of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL 33169, USA. abishayee@ularkin.org.
Kwang Seok AhnCollege of Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea. ksahn@khu.ac.kr.ORCID 0000-0002-2882-0612
Kyung Hee University · KRNational University of Singapore · SGCurtin University · AULarkin University · USTon Duc Thang University · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicDrug Resistance, MultipleDrug Resistance, NeoplasmDrug SynergismGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansNeoplasmsResveratrolStilbenesAntineoplastic Agents, PhytogenicResveratrolStilbenesapoptosiscancerchemopreventionmolecular targetsResveratroltherapy

Identifiers

PMID29194365
PMCPMC5751192
OpenAlexW2771136768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.